NCT01995786View on ClinicalTrials.gov

Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2014

Conditions
Postoperative Complications
Interventions
DEVICE

Goal Directed Fluid Therapy FloTrac/Vigileo

Trial Locations (1)

00144

Regina Elena CI, Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER

NCT01995786 - Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy | Biotech Hunter | Biotech Hunter